Barclays reported second-quarter earnings that exceeded analyst expectations, supported by a strong performance in trading …
africadailyherald
-
-
Boeing significantly narrowed its quarterly losses and posted stronger-than-expected revenue, marking a notable step forward in …
-
Shares of leading liquefied natural gas companies surged on Monday following the European Union’s announcement of a …
-
President Donald Trump has sharply reduced his previously announced deadline for Russia to cease its military operations …
-
U.S. President Donald Trump announced on Sunday a new trade agreement with the European Union, following …
-
A planet with potential for habitability has been discovered approximately 35 light years from Earth …
-
The European Medicines Agency (EMA) has issued a positive recommendation for the authorization of lenacapavir, …
-
ACCESS Newswire
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe …
-
The United Kingdom and India have signed a landmark Free Trade Agreement (FTA) valued at nearly £6 …
-
Alphabet Inc., the parent company of Google, posted stronger-than-expected second-quarter earnings, supported by robust performance in …

